FINWIRES · TerminalLIVE
FINWIRES

Daily Roundup of Key US Economic Data for April 16

-- March industrial production fell by 0.5% after a 0.7% gain in February, with manufacturing production down 0.1% overall but up 0.1% excluding a 3.7% drop in motor vehicle and parts production.

Utilities output fell by 2.3% on declines in both electricity and natural gas production, while mining production decreased by 1.2%.

The New York Federal Reserve's monthly business leaders index, a measure of services conditions, rose to minus 14.0 in April from minus 22.6 in March, still indicating contraction in the sector though at a slower rate. Other services data will be released over the coming weeks.

The Philadelphia Fed's manufacturing reading rose to 26.7 in April from 18.1 in March after the Empire State reading improved in the same month.

Initial jobless claims decreased by 11,000 to 207,000 in the week ended April 11, though the four-week average rose by 500 to 209,750, a second straight weekly increase.

Insured claims rose by 31,000 to 1.818 million in the week ended April 4, but the four-week moving average was the lowest since the week ended June 1, 2024.

Natural gas stocks rose by 59 billion cubic feet to 1.970 trillion cubic feet in the week ended April 10, up 6.8% from a year earlier and 5.8% higher than the seasonal average for the current week over the previous five years.

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR